Cerity Partners LLC Adaptive Biotechnologies Corp Transaction History

Cerity Partners LLC

  • $55.1 Billion
  • Q2 2025

A detailed history of Cerity Partners LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Cerity Partners LLC holds 454,736 shares of ADPT stock, worth $5.76 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
454,736
Previous 457,015 0.5%
Holding current value
$5.76 Million
Previous $3.4 Million 56.02%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
SELL
$6.83 - $12.16 $15,565 - $27,712
-2,279 Reduced 0.5%
454,736 $5.3 Million
Q1 2025

Apr 30, 2025
SELL
$6.07 - $8.66 $130,098 - $185,609
-21,433 Reduced 4.48%
457,015 $3.4 Million
Q4 2024

Feb 13, 2025
SELL
$4.37 - $6.78 $943,784 - $1.46 Million
-215,969 Reduced 31.1%
478,448 $2.87 Million
Q3 2024

Nov 12, 2024
BUY
$3.37 - $5.12 $865,864 - $1.32 Million
256,933 Added 58.73%
694,417 $3.56 Million
Q2 2024

Aug 13, 2024
SELL
$2.34 - $3.96 $558,698 - $945,489
-238,760 Reduced 35.31%
437,484 $1.58 Million
Q1 2024

May 14, 2024
BUY
$2.88 - $4.8 $1.56 Million - $2.59 Million
540,592 Added 398.51%
676,244 $2.17 Million
Q4 2023

Jan 26, 2024
BUY
$3.46 - $5.33 $469,355 - $723,025
135,652 New
135,652 $664,000
Q2 2023

Aug 14, 2023
SELL
$6.19 - $8.78 $52,905 - $75,042
-8,547 Reduced 3.89%
211,241 $1.42 Million
Q1 2023

May 11, 2023
BUY
$7.8 - $10.11 $479,879 - $621,997
61,523 Added 38.87%
219,788 $1.94 Million
Q4 2022

Feb 15, 2023
SELL
$6.26 - $9.34 $1,996 - $2,979
-319 Reduced 0.2%
158,265 $1.21 Million
Q3 2022

Nov 10, 2022
BUY
$6.5 - $12.67 $503,275 - $981,000
77,427 Added 95.4%
158,584 $1.13 Million
Q2 2022

Aug 10, 2022
BUY
$6.4 - $14.73 $20,627 - $47,474
3,223 Added 4.14%
81,157 $656,000
Q1 2022

Apr 25, 2022
BUY
$10.12 - $28.9 $258,404 - $737,932
25,534 Added 48.73%
77,934 $1.08 Million
Q4 2021

Feb 14, 2022
SELL
$25.17 - $36.85 $495,446 - $725,355
-19,684 Reduced 27.31%
52,400 $1.47 Million
Q3 2021

Oct 25, 2021
BUY
$30.02 - $39.87 $142,024 - $188,624
4,731 Added 7.02%
72,084 $2.45 Million
Q2 2021

Aug 11, 2021
BUY
$32.22 - $44.59 $339,179 - $469,398
10,527 Added 18.52%
67,353 $2.75 Million
Q1 2021

Aug 11, 2021
BUY
$37.26 - $67.74 $4,135 - $7,519
111 Added 0.2%
56,826 $2.29 Million
Q1 2021

May 12, 2021
BUY
$37.26 - $67.74 $444,996 - $809,018
11,943 Added 26.68%
56,715 $2.28 Million
Q4 2020

Feb 11, 2021
SELL
$45.01 - $65.47 $7,516 - $10,933
-167 Reduced 0.37%
44,772 $2.65 Million
Q3 2020

Nov 12, 2020
BUY
$35.79 - $48.81 $1.44 Million - $1.96 Million
40,156 Added 839.56%
44,939 $2.19 Million
Q2 2020

Aug 14, 2020
BUY
$24.95 - $48.38 $119,335 - $231,401
4,783 New
4,783 $231,000

Others Institutions Holding ADPT

# of Institutions
256
Shares Held
153M
Call Options Held
44.3K
Put Options Held
47.8K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $1.81B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email